[ Home | Contents | Search | Post | Reply | Next | Previous | Up ]
From:
Dr. Stephen Kracht
Password: orange
Date: 17 Mar 2008
Time: 05:54:07 -0800
Remote Name:
12.40.33.118
The interest in eScreen’s products and services has seen considerable growth over the past couple of years. There have been comments and questions recently regarding eScreen, so I thought it would be helpful to provide some basic information on the process and technology.
The eReader® device is the first and only instrumented urine drug screen in the industry (this system was cleared for marketing by the FDA in 2001). The specimen is captured in an eCup®, is sealed with a tamper-evident barcode label, scanned into the operating software called eScreen123 and placed into the eReader. The eReader‘s digital process scans the test strips incased inside the eCup lid and produces a “discard” or “send to lab” message for the collector in 3-8 minutes. Upon a “send to lab” message, the collector will print the electronic chain (complete with electronic donor/collector signatures captured during the collection). eScreen maintains relationships with SAMHSA-certified laboratories for the confirmation processing of specimens. Although laboratory partners are integrated with eScreen for the expedited electronic processing of eScreen samples, eScreen does not own or control a laboratory. This business process is kept completely separate from eScreen. Once a specimen has reached the lab, GC/MS confirmation testing is completed on the specimen. If the result is positive, it goes to the MRO of record for review and confirmation. For MROs who are part of the eScreen integrated process, they have access to these pending results online through the eScreen123 MRO Tool. There, result details can be viewed, interviews can be tracked, and final results released. Through the eScreen process, no positive result ever by-passes the MRO and goes directly to the employer. Since its release in early 2000, eScreen has made numerous upgrades, added tools and features, made adjustments so the footprint of the system is smaller in the clinic and built various integrations to further improve transfer of information.
If I can provide additional information on the eScreen process, please let me know how I can help.
Stephen Kracht D.O.
eScreen/eMro